GI Stool Testing Market 2015-2019 – Global Market Research

2015-09-16
Price :
Published : Sep-2015
No. of Pages : 61

Normal gastrointestinal (GI) functioning is essential for digestion as well as for the removal of body waste and pathogens. GI disorders are a common problem in the general population. These disorders are known to cause severe harm to the health and quality of life of an individual. These disorders include malabsorption disorders, inflammatory bowel diseases, cancer of the digestive system, colitis, and gastroenteritis. Globally, about 1.7-2 billion cases of diarrheal diseases occur every year. Also, about 1,700 million cases of C. difficile infections have been reported worldwide every year.

Stool tests are used for the diagnosis of GI disorders and help detect parasite infection, inflammation, bleeding obstruction, and tumors in the GI tract and digestive system. The diagnosis of GI diseases is commonly done through laboratory tests using antigen or culture detection from stool samples. A stool test is of two categories: fecal occult blood test (FOBT) and clinical microbiological stool tests.

These tests are either antibody-based or microbial particle-based detection methods, which include immunoassay, CLIA, and molecular diagnostic testing. Stool tests are used for the screening of colorectal cancer as well as the detection of pathogens such as C. difficile, H. pylora, Rotavirus, and Adenovirus.

The global GI stool testing market is expected to grow at a CAGR of 7.37% during 2014-2019.

Covered in this report

This report covers the present scenario and growth prospects of the global GI stool testing market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of the following products:

  • FOBT
  • Clinical microbiology stool test

The report, Global GI Stool Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global BI and analytics platform market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Clinical Genomics
  • Diasorin
  • Meridian Bioscience
  • Quidel

Other prominent vendors

  • Alere
  • Beckman Coulter
  • bioMérieux
  • Bio-Rad Laboratories
  • CARE Products
  • Cenogenics
  • EIKEN CHEMICAL
  • Epigenomics
  • Epitope Diagnostic
  • Exact Sciences
  • Helena Laboratories
  • Hemosure
  • Mobidiag
  • Orion Diagnostica
  • Pinnacle BioLabs
  • Polymedco
  • Propper Manufacturing
  • ScheBo Biotech
  • Trinity Biotech

Key market driver

  • Increased incidence of C. difficile infections
  • For a full, detailed list, view our report

Key market challenge

  • Accurate diagnostic testing
  • For a full, detailed list, view our report

Key market trend

  • Focus on rapid and early diagnosis
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Diagnostics
Publisher : Technavio
More Reports
Title Price Buy Now

Global Immunodiagnostics Market 2017-2021

The global immunodiagnostics market is in the moderate growth stage. The integration of mature clinical chemistry analyzers and restricted specificity and sensitivity of immunoassays have generated demand for integrated immunochemistry analyzers. The increasing volume of tests conducted due to rise in laboratory consolidation has driven the trend of automated analyzers globally. The analysts forecast global immunodiagnostics market to grow at a CAGR of 7.80% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global immunodiagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of immunodiagnostics devices.. The market is divided into the foll......
$3500

Global HPV Testing Market 2016-2020

According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample take......
$2500

Global Blood Stream Infection Testing Market 2016-2020

The presence of bacteria and fungi in blood leads to blood stream infections. Bacteria and fungi enter into the blood and cause severe complications and infections such as pneumonia, meningitis, sepsis and AIDS. Bloodstream infections are caused when bacteria enter the bloodstream; this may occur through a wound, injection, or through a surgical procedure. Symptoms of bacteremia may include fever, chills, malaise, nausea, diarrhea, shortness of breath, and vomiting. This analysts forecast the global blood stream infection testing market to grow at a CAGR of 7.75% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global blood stream infection testing market for 2016-2020. To calculate the market size, the repo......
$2500

Global Professional Diagnostics Market 2016-2020

The global professional diagnostics market is expected to grow at a high rate in the forecast period. Factors such as increasing aging population and rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the increasingly diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities, and new product launches are expected to have a positive impact on the market over the next few years. This analyst forecast the global professional diagnostics market to grow at a CAGR of 6.76% during the period 2016-2020. Covered in this report This report covers the present scenario and the......
$2500

Global Point-of-Care Coagulation Testing Market 2016-2020

Coagulation testing measures the ability of blood to form a clot. Clotting is the process of the blood converting from a liquid into a gel form. Coagulation tests are carried out to detect clotting disorders such as hemorrhage and thrombosis. Many types of coagulation tests exist, including complete blood count, factor V assay, fibrinogen level, PT, platelet count, TT, and bleeding time. The analysts forecast global point-of-care coagulation testing market to grow at a CAGR of 6.53% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global point-of-care coagulation testing market for 2016-2020. A 360-degree view of the market, based on products, application, and technology segments, has been considered for ma......
$2500

Global Enteric Disease Testing Market 2016-2020

Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, and impaired cognitive development. Enteric disease testing is performed on individuals using rapid tests, culture tests, enzyme immunoassay tests, and immunoassay tests. The analysts forecast global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calcula......
$2500

Global Gonorrhea Diagnostics Market 2016-2020

Gonorrhea is a sexually transmitted disease that can affect both males and females. It is caused by the bacterium Neisseria gonorrhoeae. The bacterium grows in warm and moist areas of uterus, reproductive tract, fallopian tubes, and urethra. It can also grow and infect the throat, mouth, and anus. Women are more likely to contract this disease than men. Based on the Sexually Transmitted Disease Surveillance 2009 report, the Centers for Disease Control and Prevention (CDC) estimated that gonorrhea is the second most common communicable disease in the US. The analysts forecast global gonorrhea diagnostics market to grow at a CAGR of 9.25% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global gonorrhea diagn......
$2500

Global Transplant Diagnostics Market 2016-2020

Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients. The analysts forecast global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global......
$2500

IVD Market in Europe 2016-2020

IVD tests help diagnose, monitor, and assess medical conditions, diseases, and infections in a controlled environment. These tests help in early diagnosis of diseases by enhancing control on test procedures and provide accurate results, leading to quality treatment and shorter hospital stays. They are also minimally invasive and help in lowering treatment costs. Manufacturers develop reagents, analytical instruments such as automated analyzers, and accessory products including software to measure the quality and parameters of samples. The analysts forecast IVD market in Europe to grow at a CAGR of 4.78% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the IVD market in Europe for 2016-2020. To calculate the mar......
$2500

Global Rapid Diagnostics Market 2016-2020

Rapid diagnostic tests are diagnostic assays designed for low-resource settings that provide faster results. These can be carried out either at a patient's bedside or in a clinical setting. These devices are simple to operate and read, have a low cost, and are specific, sensitive, and stable at extreme temperatures. They also provide quick results. Rapid diagnostics is the fastest-growing segment in in vitro diagnostics (IVD). Rapid diagnostic tests include agglutination, lateral flow, flow through, solid phase, and nucleic-acid amplification tests. Diagnostic devices are used to detect and measure blood glucose and coagulation levels, cardiac biomarkers, infectious diseases, hemoglobin concentration, five-part differential blood count, and pregnancy and fertility status. These tests can b......
$2500